Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. Shaban
Safety and Effectiveness of Biphasic Insulin Aspart 30/70 (NovoMix®30) When Switching From Human Premix Insulin in Patients With Type 2 Diabetes: Subgroup Analysis From the 6-Month IMPROVE™ Observational Study
International Journal of Clinical Practice
Medicine
Related publications
15 Years of Experience With Biphasic Insulin Aspart 30 in Type 2 Diabetes
Drugs in R and D
Pharmacology
Safety and Effectiveness of Biphasic Insulin Aspart 30 in Different Age-Groups: A1chieve Sub-Analysis
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Use of Biphasic Insulin Aspart 30 in Type 2 Diabetes Treatment: Expert Panel Recommendations
Turkish Journal of Endocrinology and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
Biphasic Insulin Aspart 30 Therapy in Insulin-Naïve and Insulin-Experienced Patients With Type 2 Diabetes: Results From the Jordanian Subgroup of the A<sub>1</Sub>chieve Study
Journal of Diabetes Mellitus
Comparison of a Soluble Co-Formulation of Insulin Degludec/Insulin Aspart vs Biphasic Insulin Aspart 30 in Type 2 Diabetes: A Randomised Trial
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
Continuous Glucose Monitoring Guided Assessment of Concentrated 200 IU/Ml rDNA Human Premix 30/70 Insulin in Type 2 Diabetes Mellitus Patients
International Journal of Diabetes and Clinical Research
Switching From Glargine+insulin Aspart to Glargine+insulin Aspart 30 Before Breakfast Combined With Exercise After Dinner and Dividing Meals for the Treatment of Type 2 Diabetes Patients With Poor Glucose Control – A Prospective Cohort Study
BMC Endocrine Disorders
Medicine
Endocrinology
Metabolism
Diabetes
Efficacy and Safety of Three-Times-Daily Versus Twice-Daily Biphasic Insulin Aspart 30 in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Combined With Oral Antidiabetic Drugs
Diabetes Research and Clinical Practice
Internal Medicine
Endocrinology
Metabolism
Medicine
Diabetes
Safety, Immunogenicity and Glycemic Control of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart in People With Diabetes Also Using Insulin Glargine: 12-Month Results From the GEMELLI 1 Trial
Diabetes Technology and Therapeutics
Medicine
Endocrinology
Medical Laboratory Technology
Metabolism
Diabetes
